1. Home
  2. KVYO vs CRL Comparison

KVYO vs CRL Comparison

Compare KVYO & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$29.47

Market Cap

8.3B

Sector

N/A

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$184.50

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
CRL
Founded
2012
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.0B
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
KVYO
CRL
Price
$29.47
$184.50
Analyst Decision
Strong Buy
Buy
Analyst Count
24
15
Target Price
$43.17
$190.15
AVG Volume (30 Days)
2.4M
907.5K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,153,988,000.00
$4,023,704,000.00
Revenue This Year
$32.38
N/A
Revenue Next Year
$21.60
$1.66
P/E Ratio
N/A
N/A
Revenue Growth
32.81
N/A
52 Week Low
$23.44
$91.86
52 Week High
$49.55
$202.72

Technical Indicators

Market Signals
Indicator
KVYO
CRL
Relative Strength Index (RSI) 58.51 62.56
Support Level $27.72 $176.37
Resistance Level $28.89 $186.72
Average True Range (ATR) 1.09 5.89
MACD 0.16 1.82
Stochastic Oscillator 72.82 92.60

Price Performance

Historical Comparison
KVYO
CRL

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: